Research misconduct and data fraud in clinical trials: prevalence and causal factors

International Journal of Clinical Oncology

Volumn 21, Issue 1, 2016, Pages 15-21

  George, Stephen L ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Fraud; Research misconduct

Indexed keywords

CAUSAL MODELING; CLINICAL TRIAL (TOPIC); COMPUTER SECURITY; FRAUD; HUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; RESEARCH ETHICS; REVIEW; SCIENTIFIC MISCONDUCT; ADULT; FEMALE; MALE;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; FRAUD; HUMANS; MALE; PREVALENCE; SCIENTIFIC MISCONDUCT;

EID: 84957849910     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-015-0887-3     Document Type: Review

References (61)

1. George SL, Buyse M (2015) Data fraud in clinical trials. Clin Investig (Lond.) 15(2):161–173
2. George SL (1997) Perspectives on scientific misconduct and fraud in clinical trials. Chance 10(4):3–5
3. Fisher B, Redmond CK (1994) Fraud in breast-cancer trials. N Engl J Med 330(20):1458–1460
4. Weir C, Murray G (2011) Fraud in clinical trials. Significance 8(4):164–168. doi:10.1111/j.1740-9713.2011.00521.x
5. Horton R (2000) After Bezwoda. Lancet 355(9208):942–943. doi:10.1016/s0140-6736(00)90006-0
6. Weiss RB, Rifkin RM, Stewart FM et al (2000) High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study. Lancet 355(9208):999–1003
7. Eichenwald K, Kolata G (1999) A doctor’s drug studies turn into fraud. The New York times on the Web, A1–A16
8. Swaminathan V, Avery M (2012) FDA enforcement of criminal liability for clinical investigator fraud. Hastings Sci Tech Law J 4:325–356
9. Birch DM, Cohen G (2001) How a cancer trial ended in betrayal. http://www.baltimoresun.com/bal-te.research24jun24-story.html#page=1. Accessed 12 Jan 2015
10. Grant B (2009) Biotech’s baddies. Scientist 23(4):48
11. Carlisle J (2012) The analysis of 168 randomised controlled trials to test data integrity. Anaesthesia 67(5):521–537
12. Fujii Y (2000) Reply to “Reported data on granisetron and postoperative nausea and vomiting by Fujii et al. are incredibly nice!” [letter]. Anesth Analg 90(4):1004
13. Fujii Y (2012) Reply to “The analysis of 168 randomised controlled trials to test data integrity” [letter]. Anaesthesia 67(6):669–670
14. Kranke P, Apfel CC, Roewer N (2000) Reported data on granisetron and postoperative nausea and vomiting by Fujii et al. are incredibly nice! [letter]. Anesth Analg 90(4):1004
15. Miller D (2012) Retraction of articles written by Dr. Yoshitaka Fujii. Can J Anesth/J Can Anesth 59(12):1081–1088. doi:10.1007/s12630-012-9802-9
16. Normile D (2012) A new record for retractions? http://news.sciencemag.org/education/2012/04/newrecord-retractions. Accessed 13 Aug 2015
17. Baggerly KA, Coombes KR (2009) Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology. Ann Appl Stat 3:1309–1334
18. Oransky I (2014) Novartis Diovan scandal claims two more papers. http://retractionwatch.com/2014/04/02/novartis-diovan-scandal-claims-two-more-papers/. Accessed 4 May 2015
19. Husten L (2013) Diovan data was fabricated, say Japanese Health Minister and university officials. http://www.forbes.com/sites/larryhusten/2013/07/12/diovan-data-was-fabricated-say-japanese-health-minister-and-university-officials/. Accessed 3 July 2015
20. Federal Register (2005) Public health service policies on research misconduct final rule (42 CFR part 93.103). http://www.ecfr.gov/cgi-bin/text-idx?SID=0b07ed68cf889962cae6c2b45d89150b&node=pt42.1.93&rgn=div5. Accessed 4 July 2015
21. National Institutes of Health (2015) Research integrity. http://grants.nih.gov/grants/research_integrity/research_misconduct.htm. Accessed 4 July 2015
22. Federal Register (2002) National science foundation policies on research misconduct (45 CFR part 689) http://www.nsf.gov/oig/regulations/. Accessed 4 July 2015
23. American Psychological Association (2015) Research misconduct. https://apa.org/research/responsible/misconduct/index.aspx. Accessed 4 July 2015
24. U.S. Food and Drug Administration (2004) Guidance for industry: the use of clinical holds following clinical investigator misconduct. http://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126997.pdf. Accessed 25 July 2015
25. Scott-Lichter D, Editorial Policy Committee, Council of Scientific Editors (2006) CSE’s white paper on promoting integrity in scientific journal publications. CSE, Reston
26. Universities UK (2012) The concordat to support research integrity http://www.universitiesuk.ac.uk/highereducation/Pages/Theconcordattosupportresearchintegrity.aspx#.VZgN03J3EdU. Accessed 4 July 2015
27. Breen KJ (2003) Misconduct in medical research: whose responsibility? Intern Med J 33(4):186–191
28. Habermann B, Broome M, Pryor ER et al (2010) Research coordinators’ experiences with scientific misconduct and research integrity. Nurs Res 59(1):51–57
29. Martinson BC, Anderson MS, De Vries R (2005) Scientists behaving badly. Nature 435(7043):737–738. doi:10.1038/435737a
30. Weed DL (1998) Preventing scientific misconduct. Am J Public Health 88(1):125–129
31. Wilmshurst P (1997) The code of silence. Lancet 349(9051):567–569
32. Sarwar U, Nicolaou M (2012) Fraud and deceit in medical research. J Res Med Sci 17(11):1077–1081
33. Steneck NH (2006) Fostering integrity in research: definitions, current knowledge, and future directions. Sci Eng Ethics 12(1):53–74
34. Claxton LD (2005) Scientific authorship: part 1. A window into scientific fraud? Mutat Res 589(1):17–30
35. Hone J (1993) Combating fraud and misconduct in medical research. Scrip Mag 14(March):14–15
36. Reynolds SM (2004) ORI findings of scientific misconduct in clinical trials and publicly funded research, 1992–2002. Clin Trials 1(6):509–516. doi:10.1191/1740774504cn048oa
37. Weiss RB, Vogelzang NJ, Peterson BA et al (1993) A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. J Am Med Assoc 270(4):459–464
38. Hamilton D (1992) In the trenches, doubts about scientific integrity. Science 255(5052):1636. doi:10.1126/science.11642983
39. Ranstam J, Buyse M, George SL et al (2000) Fraud in medical research: an international survey of biostatisticians. Control Clin Trials 21(5):415–427. doi:10.1016/s0197-2456(00)00069-6
40. Kalichman MW, Friedman PJ (1992) A pilot study of biomedical trainees’ perceptions concerning research ethics. Acad Med 67(11):769–775
41. Swazey JP, Anderson MS, Lewis KS (1993) Ethical problems in academic research. Am Sci 81:542–553
42. Titus SL, Wells JA, Rhoades LJ (2008) Repairing research integrity. Nature 453(7198):980–982
43. John LK, Loewenstein G, Prelec D (2012) Measuring the prevalence of questionable research practices with incentives for truth telling. Psychol Sci 23(5):524–532. doi:10.1177/0956797611430953
44. Martinson BC, Crain AL, Anderson MS et al (2009) Institutions’ expectations for researchers’ self-funding, federal grant holding, and private industry involvement: manifold drivers of self-Interest and researcher behavior. Acad Med 84(11):1491–1499
45. Koshland DE (1987) Fraud in science. Science 235:141–142
46. Blair G, Imai K, Zhou Y-Y (2015) Design and analysis of the randomized response technique (in press). J Am Stat Assoc
47. Warner SL (1965) Randomized response: a survey technique for eliminating evasive answer bias. J Am Stat Assoc 60(309):63–69
48. List JA, Bailey CD, Euzent PJ et al (2001) Academic economists behaving badly? A survey on three areas of unethical behavior. Econ Inq 39(1):162–170
49. Fanelli D (2009) How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 4(5):e5738. doi:10.1371/journal.pone.0005738
50. Smith R (2006) Research misconduct: the poisoning of the well. J R Soc Med 99(5):232–237. doi:10.1258/jrsm.99.5.232
51. Sovacool BK (2008) Exploring scientific misconduct: isolated individuals, impure institutions, or an inevitable idiom of modern science? Bioeth Inq 5(4):271–282. doi:10.1007/s11673-008-9113-6
52. Davis MS, Riske-Morris M, Diaz SR (2007) Causal factors implicated in research misconduct: evidence from ORI case files. Sci Eng Ethics 13(4):395–414. doi:10.1007/s11948-007-9045-2
53. Chubin DE (1985) Misconduct in research: an issue of science policy and practice. Minerva 23(2):175–202. doi:10.1007/bf01099941
54. De Vries R, Anderson MS, Martinson BC (2006) Normal misbehavior: scientists talk about the ethics of research. J Empir Res Hum Res Eth 1(1):43–50
55. Gaddis B, Helton-Fauth W, Scott G et al (2003) Development of two measures of climate for scientific organizations. Account Res 10(4):253–288
56. Adams D, Pimple KD (2005) Research misconduct and crime lessons from criminal science on preventing misconduct and promoting integrity. Account Res 12(3):225–240
57. Ariely D (2012) The honest truth about dishonesty. Harper Collins Publishers, New York
58. Swazey JP, Scher SR (1982) Whistleblowing in biomedical research. Government Printing Office, Washington
59. Poisson R (1994) Fraud in breast-cancer trials [letter]. N Engl J Med 330(20):1460
60. Buyse M, George SL, Evans S et al (1999) The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med 18(24):3435–3451
61. Knatterud GL, Rockhold FW, George SL et al (1998) Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials 19(5):477–493. doi:10.1016/s0197-2456(98)00033-6